COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 101 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $348,000 | -2.8% | 19,900 | -9.1% | 0.06% | -3.4% |
| Q1 2020 | $358,000 | -20.6% | 21,900 | 0.0% | 0.06% | +26.1% |
| Q4 2019 | $451,000 | -9.4% | 21,900 | -49.5% | 0.05% | -9.8% |
| Q3 2019 | $498,000 | -20.1% | 43,400 | -8.4% | 0.05% | -15.0% |
| Q2 2019 | $623,000 | -14.1% | 47,400 | -1.0% | 0.06% | -16.7% |
| Q1 2019 | $725,000 | -11.8% | 47,900 | 0.0% | 0.07% | -20.0% |
| Q4 2018 | $822,000 | +163.5% | 47,900 | +125.9% | 0.09% | +233.3% |
| Q3 2018 | $312,000 | -59.1% | 21,200 | -33.8% | 0.03% | -60.3% |
| Q2 2018 | $763,000 | -6.7% | 32,000 | 0.0% | 0.07% | -11.7% |
| Q1 2018 | $818,000 | +38.4% | 32,000 | 0.0% | 0.08% | +42.6% |
| Q4 2017 | $591,000 | +108.8% | 32,000 | +18.5% | 0.05% | +107.7% |
| Q3 2017 | $283,000 | – | 27,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |